Results 191 to 200 of about 19,560 (233)

Intravitreal Bevacizumab for Diabetic Retinopathy

Current Diabetes Reviews, 2009
Diabetic retinopathy (DR) remains the major threat to sight in the working age population. Diabetic macular edema (DME) is a manifestation of DR that produces loss of central vision. Macular edema within 1 disk diameter of the fovea is present in 9% of the diabetic population.
J Fernando, Arevalo, Rafael A, Garcia-Amaris   +1 more
openaire   +2 more sources

Intravitreal Bevacizumab for Incontinentia Pigmenti

Journal of Pediatric Ophthalmology & Strabismus, 2013
Two eyes of two siblings affected with incontinentia pigmenti having severe proliferative retinopathy are reported. Both cases showed complete resolution of new vessels after a single injection of intravitreal bevacizumab. At 7 months of follow-up, the first case revealed vascularization to the mid-periphery including a vascularized fovea (
Parag K, Shah, Sandeep, Bachu, Venkatapathy, Narendran, Narendran, Kalpana, Jeevamala, David, Chakravarthi R, Srinivas   +5 more
openaire   +2 more sources

Intravitreal Bevacizumab for Retinopathy of Prematurity

Journal of Ocular Pharmacology and Therapeutics, 2011
To evaluate the therapeutic effect of a single intravitreal injection of bevacizumab for treatment of threshold retinopathy in retinopathy of prematurity (ROP).The retrospective study consisted of all infants who developed threshold ROP in fundus zone I or zone II and who consecutively received an intravitreal injection of bevacizumab (0.375 mg, 0.03 ...
Björn C, Harder, Stefan, von Baltz, Jost B, Jonas, Frank C, Schlichtenbrede   +3 more
openaire   +2 more sources

Meta-herpetic ulcer following intravitreal bevacizumab

European Journal of Ophthalmology, 2020
Purpose: To report a case of meta-herpetic ulcer that developed after intravitreal bevacizumab injection. Methods: A 55-year-old man with type 2 diabetes mellitus and nephropathy received intravitreal injection of bevacizumab in his right eye for proliferative diabetic retinopathy with macular edema.
Geeta Behera, Tanmay Gokhale, Amit Kumar Deb, Krishna Ramesh Babu   +3 more
openaire   +2 more sources

Intravitreal bevacizumab for idiopathic choroidal neovascularization

Journal of American Association for Pediatric Ophthalmology and Strabismus, 2009
An otherwise healthy 8-year-old girl with active juxtapapillary choroidal neovascularization was successfully treated with two intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and subretinal and intraretinal serous fluid resorbed, with improvement in visual acuity from 20/400 ...
Mehmet, Cakir, Osman, Cekiç, O Faruk, Yilmaz   +2 more
openaire   +2 more sources

Osteonecrosis After Administration of Intravitreous Bevacizumab

Journal of Oral and Maxillofacial Surgery, 2012
Bevacizumab is a recombinant humanized monoclonal immunoglobulin G1 antibody (149 kDa) that binds to and inhibits the biologic activity of all isoforms of human vascular endothelial growth factor. It has been used for the treatment of a myriad of malignancies, including metastatic colon and nonsmall cell lung cancers.
Renato Nicolás, Hopp, Juliana, Pucci, Alan Roger, Santos-Silva, Jacks, Jorge   +3 more
openaire   +2 more sources

Retinal vascular events after intravitreal bevacizumab

Acta Ophthalmologica, 2009
Acta Ophthalmol. 2010: 88: 730–735Abstract.Purpose:  To record retinal vascular events following intravitreal bevacizumab injection.Methods:  Collaborative multi‐centre retrospective case series.Results:  Eight patients were documented to have central retinal artery occlusion (four patients), branch retinal artery occlusion, capillary occlusion ...
Ahmad M, Mansour, Leon A, Bynoe, John C, Welch, Richard, Pesavento, Padmamalini, Mahendradas, Focke, Ziemssen, Sivakami A, Pai   +6 more
openaire   +2 more sources

Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization

American Journal of Ophthalmology, 2008
To assess the role of bevacizumab in inflammatory ocular neovascularization.Retrospective, multicenter, consecutive case series of inflammatory ocular neovascularization.Patients with inflammatory ocular neovascularization of varying causes for whom standard therapy failed were treated with intravitreal injection of bevacizumab.
Ahmad M, Mansour, Friederike, Mackensen, J Fernando, Arevalo, Focke, Ziemssen, Padmamalini, Mahendradas, Abla, Mehio-Sibai, Nicholas, Hrisomalos, Timothy Y Y, Lai, David, Dodwell, Wai-Man, Chan, Thomas, Ness, Alay S, Banker, Sivakami A, Pai, Maria H, Berrocal, Rania, Tohme, Arnd, Heiligenhaus, Ziad F, Bashshur, Moncef, Khairallah, Khalil M, Salem, Frank N, Hrisomalos, Matthew H, Wood, Wilson, Heriot, Alfredo, Adan, Atul, Kumar, Lyndell, Lim, Anthony, Hall, Matthias, Becker   +26 more
openaire   +3 more sources

Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization

Ocular Immunology and Inflammation, 2009
To report 5 cases of inflammatory choroidal neovascularization (CNV) that were treated with intravitreal bevacizumab.Six eyes of 5 patients with uveitic CNV were treated with 2.5 mg/0.1 mL of intravitreal bevacizumab. Main outcome measures were the changes in BCVA and reduction in the size of the CNV.The mean follow-up time was 15.3 months.
Priyanka P, Doctor, Pooja, Bhat, Reema, Sayed, C Stephen, Foster   +3 more
openaire   +2 more sources

Intravitreal Bevacizumab for Myopic Choroidal Neovascularization

Ophthalmic Surgery, Lasers and Imaging Retina, 2008
Background and Objective: To evaluate the effect of intravitreal bevacizumab on visual acuity in patients with myopic choroidal neovascularization. Patients and Methods: The retrospective case series study included 13 patients with myopic choroidal neovascularization who received ...
Florian, Rensch, Ulrich H M, Spandau, Frank, Schlichtenbrede, Stefan, von Baltz, Teodosio, Libondi, Jost B, Jonas, Urs, Vossmerbaeumer   +6 more
openaire   +2 more sources